Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design

[1]  E. Canestrari,et al.  Human Platelet Lysate Media Supplement Supports Lentiviral Transduction and Expansion of Human T Lymphocytes While Maintaining Memory Phenotype , 2019, Journal of immunology research.

[2]  K. Bieback,et al.  Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: A joint publication from the AABB and the International Society of Cell Therapy. , 2019, Cytotherapy.

[3]  G. Artioli,et al.  The Physiological Roles of Carnosine and β-Alanine in Exercising Human Skeletal Muscle , 2019, Medicine and science in sports and exercise.

[4]  S. Ghassemi,et al.  ‘Evidence of improved transduction and preservation of relevant T cell subpopulations using different media conditions: Towards a novel CAR-T media formulation’ , 2019, The Journal of Immunology.

[5]  E. Pearce,et al.  Metabolic interventions in the immune response to cancer , 2019, Nature Reviews Immunology.

[6]  K. Patel,et al.  Platelet releasate promotes skeletal myogenesis by increasing muscle stem cell commitment to differentiation and accelerates muscle regeneration following acute injury , 2018, Acta physiologica.

[7]  S. Grupp,et al.  Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells , 2018, Cancer Immunology Research.

[8]  P. Jakeman,et al.  Regulation of muscle protein synthesis in an in vitro cell model using ex vivo human serum , 2018, Experimental physiology.

[9]  Hans Bitter,et al.  Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia , 2018, Nature Medicine.

[10]  C. June,et al.  The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations , 2018, Scientific Reports.

[11]  Omkar U. Kawalekar,et al.  CAR T cell immunotherapy for human cancer , 2018, Science.

[12]  Edmond J. Breen,et al.  Red blood cells are dynamic reservoirs of cytokines , 2018, Scientific Reports.

[13]  F. Kruse,et al.  Optimized human platelet lysate as novel basis for a serum‐, xeno‐, and additive‐free corneal endothelial cell and tissue culture , 2018, Journal of tissue engineering and regenerative medicine.

[14]  S. Levison,et al.  Tethered growth factors on biocompatible scaffolds improve stemness of cultured rat and human neural stem cells and growth of oligodendrocyte progenitors. , 2017, Methods.

[15]  Z. Mourelatos,et al.  High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model , 2017, Cancer Immunology Research.

[16]  Xin Gao,et al.  Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase , 2017, Cell.

[17]  Mithat Gönen,et al.  Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection , 2017, Nature.

[18]  E. Seifried,et al.  Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies , 2017, Cancer Immunology, Immunotherapy.

[19]  M. Mann,et al.  L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity , 2016, Cell.

[20]  Brian Keith,et al.  Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells. , 2016, Immunity.

[21]  L. Tsung,et al.  The Effects of Platelet-Rich Plasma on Cell Proliferation and Adipogenic Potential of Adipose-Derived Stem Cells , 2015 .

[22]  Na Li,et al.  Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma , 2015, Science Translational Medicine.

[23]  Pamela A Shaw,et al.  Chimeric antigen receptor T cells for sustained remissions in leukemia. , 2014, The New England journal of medicine.

[24]  G. Aldini,et al.  Physiology and pathophysiology of carnosine. , 2013, Physiological reviews.

[25]  P. Muranski,et al.  Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. , 2013, The Journal of clinical investigation.

[26]  Wayne W. Hancock,et al.  Substrate Rigidity Regulates Human T Cell Activation and Proliferation , 2012, The Journal of Immunology.

[27]  Fernando A. Arosa,et al.  Red blood cells release factors with growth and survival bioactivities for normal and leukemic T cells , 2011, Immunology and cell biology.

[28]  Hiranmoy Das,et al.  Stem Cell Therapy with Overexpressed VEGF and PDGF Genes Improves Cardiac Function in a Rat Infarct Model , 2009, PloS one.

[29]  H. Stenmark.  Rab GTPases as coordinators of vesicle traffic , 2009, Nature Reviews Molecular Cell Biology.

[30]  S. Vandenberg,et al.  PDGFRα-Positive B Cells Are Neural Stem Cells in the Adult SVZ that Form Glioma-like Growths in Response to Increased PDGF Signaling , 2006, Neuron.

[31]  K. Forsberg-Nilsson,et al.  Immature Neurons From CNS Stem Cells Proliferate in Response to Platelet-Derived Growth Factor , 2001, The Journal of Neuroscience.

[32]  Yvonne Barnett,et al.  The effects of carnosine on oxidative DNA damage levels and in vitro lifespan in human peripheral blood derived CD4+T cell clones , 2001, Mechanisms of Ageing and Development.